Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 31st October 2022
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Common racehorse drug could raise risk of sudden death
The scientists identified a significant risk factor associated with horses being given furosemide on race day.
Researchers conduct the first-ever large-scale study of Thoroughbred racing fatalities.

Researchers have discovered that a common drug used in Thoroughbred racehorses could increase the risk of sudden death.

The first-of-its-kind study analysing data from more than four million starts in horse racing across the USA and Canada found that around one in 10,000 resulted in a race-day sudden death.

Scientists identified a significant risk factor associated with the horses being given furosemide on race day. Horses given the drug were 62 per cent more likely to die suddenly, when compared with horses not given furosemide. 

Furosemide is widely used in the US on race days to prevent pulmonary bleeding and is associated with enhanced racing performance. Consequently, 94 per cent of horse starts in the study had been administered with the drug.
 
Scientists discovered that it could also be possible to identify horses at risk of sudden death before they experience it – for example, due to previous injury and interruption to training. Other risk factors highlighted by the study were horse age and sex, season, purse of race and race distance.

Study author Dr Euan Bennet, from the University of Glasgow's School of Biodiversity, One Health and Veterinary Medicine, commented: “This study suggests that a risk profile, identifying which horses are at the greatest risk of sudden death, may be possible. Given how rare the outcome is, further work is required to establish any potential interventions which might contribute to a reduction in sudden deaths. 

“On the association between furosemide use and sudden death, the fact that furosemide use is so common makes this result particularly remarkable given the statistical power of this large-scale study. Discussions around the ethics of race day administration of drugs should factor in potential risks such as those identified here, and further work is required to understand exactly why we identified this association.”

The study, ‘Fifteen risk factors associated with sudden death in Thoroughbred racehorses in North America (2009-2021),’ is published in the Journal of the American Veterinary Medicine Association. 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.